ClinicalTrials.Veeva

Menu

Glymphatic MRI Study

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Not yet enrolling

Conditions

Sleep Deprivation

Treatments

Other: No interventinon

Study type

Observational

Funder types

Other

Identifiers

NCT06452459
IT Gadolinium Study

Details and patient eligibility

About

This study aims at identifying neuroimaging markers of glymphatic function in humans.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to undergo MRI without anesthesia
  • Calculated GFR greater or equal to 60 mL/min/1.73 m2

Exclusion criteria

  • Inability to obtain consent
  • Subject is incarcerated, pregnant, or lactating or suspects they may be pregnant
  • Known allergic or hypersensitivity reactions to gadolinium
  • Three or more drug allergies from separate drug classes
  • Recent or expected beed for imaging with iodinated contrast
  • Contraindications to MRI: claustrophobia, weight greater than maximum MRI scanner capacity, presence of metallic foreign body, or implanted devices not documented as MRI safe
  • History of neurosurgical procedure or cervical surgery
  • Current use of anticoagulation medications
  • Contraindication to lumbar puncture (creatinine or INR elevated above laboratory standard cutoffs)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems